XML 36 R22.htm IDEA: XBRL DOCUMENT v3.8.0.1
Summary of Significant Accounting Policies - Financial Instruments (Details)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2017
USD ($)
shares
Sep. 30, 2017
USD ($)
item
Dec. 31, 2016
USD ($)
Sep. 30, 2016
USD ($)
Dec. 31, 2015
USD ($)
Financial Instruments and Concentration of Credit Risk          
Number of financial institutions in the U.S. in which cash and cash equivalents are primarily maintained | item   3      
Marketable securities held by entity $ 0 $ 0 $ 0    
Cash and Cash Equivalents          
Cash and cash equivalents 194,851,000 194,851,000 159,964,000 $ 196,000,000 $ 212,283,000
Noncash Investing Activities          
Accrued capital expenditures   120,000 356,000    
Aggregate principal amount of Convertible 3,022,000 3,022,000 $ 96,965,000    
Convertible Notes          
Noncash Investing Activities          
Aggregate principal amount of Convertible $ 96,900,000 $ 96,900,000      
Shares issued with debt conversion (in shares) | shares 25,882,421